# Merck & Co. Inc – FDA Inspection, Sep 6, 2019

Source: https://www.keypedia.com/records/fda_inspections/merck-co-inc/64a70c11-e5e9-499f-bbb8-71fe4817fc59
Source feed: FDA_Inspections

> FDA inspection 1101464 of Merck & Co. Inc, September 06, 2019. Classification: No Action Indicated (NAI). 1 citation under 21 CFR part 312. Form 483 issued. 15 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1101464
- Company Name: Merck & Co. Inc
- Inspection Date: 2019-09-06
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1329118 - 2026-08-14
- FDA Inspection 1305632 - 2026-03-13
- [FDA Inspection 1283890 - 2025-12-18](https://www.keypedia.com/records/fda_inspections/merck-co-inc/3db085e5-9756-4923-a078-ed1c7815373b)
- FDA Inspection 1262774 - 2025-05-16
- FDA Inspection 1264192 - 2025-03-27

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/peter-r-lenahan/c695dac2-5447-434b-801e-f95e6acf05f1)

Company: https://www.keypedia.com/companies/merck-co-inc/a46a094a-b27d-49bf-bde5-42441f92c622

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c